Nat Commun:利用细胞能量来进行癌症治疗

2014-03-19 Nature中文网 Nature中文网

能够利用一个癌细胞内的“能量分子”来触发药物在肿瘤所在位置的释放的一个药物载体,被发现能成功治疗小鼠的癌症。发表在本期Nature Communications上的这些发现也许能为治疗癌症提供另一个策略。Figure 1: Schematic design of the ATP-triggered Dox release system. 纳米颗粒能向肿瘤输送药物,但需要在选择性地定向肿瘤细胞方面

能够利用一个癌细胞内的“能量分子”来触发药物在肿瘤所在位置的释放的一个药物载体,被发现能成功治疗小鼠的癌症。发表在本期Nature Communications上的这些发现也许能为治疗癌症提供另一个策略。【原文下载】


Figure 1: Schematic design of the ATP-triggered Dox release system.

纳米颗粒能向肿瘤输送药物,但需要在选择性地定向肿瘤细胞方面有所改进。癌细胞经常含有为代谢提供能量的高水平ATP,这一点有可能被用于治疗。Zhen Gu及同事描述了一种纳米颗粒载体,它利用高水平的ATP来触发化疗药物Doxorubicin的释放。在有ATP存在的情况下,该载体能发生形状变化,导致药物的释放。他们发现,在实验室中这种方法在培养的细胞内和在小鼠体内都能增强由Doxorubicin诱导的癌细胞死亡。这些发现可能会导致用于将化疗药物输送到癌细胞的新策略的问世。

原始出处:

Ran Mo,Tianyue Jiang,Rocco DiSanto,Wanyi Tai & Zhen Gu.ATP-triggered anticancer drug delivery.Nature Communications 5, Article number: 3364 doi:10.1038/ncomms4364 【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879975, encodeId=e3b518e99759d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 18 21:35:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695523, encodeId=09231695523d5, content=<a href='/topic/show?id=a8aee800603' target=_blank style='color:#2F92EE;'>#细胞能量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78006, encryptionId=a8aee800603, topicName=细胞能量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c529824825, createdName=sjzlzc017, createdTime=Fri Mar 28 02:35:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844140, encodeId=d4b21844140af, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Feb 16 23:35:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086693, encodeId=8d07208669383, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Nov 09 20:35:00 CST 2014, time=2014-11-09, status=1, ipAttribution=)]
    2014-06-18 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879975, encodeId=e3b518e99759d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 18 21:35:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695523, encodeId=09231695523d5, content=<a href='/topic/show?id=a8aee800603' target=_blank style='color:#2F92EE;'>#细胞能量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78006, encryptionId=a8aee800603, topicName=细胞能量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c529824825, createdName=sjzlzc017, createdTime=Fri Mar 28 02:35:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844140, encodeId=d4b21844140af, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Feb 16 23:35:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086693, encodeId=8d07208669383, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Nov 09 20:35:00 CST 2014, time=2014-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879975, encodeId=e3b518e99759d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 18 21:35:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695523, encodeId=09231695523d5, content=<a href='/topic/show?id=a8aee800603' target=_blank style='color:#2F92EE;'>#细胞能量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78006, encryptionId=a8aee800603, topicName=细胞能量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c529824825, createdName=sjzlzc017, createdTime=Fri Mar 28 02:35:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844140, encodeId=d4b21844140af, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Feb 16 23:35:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086693, encodeId=8d07208669383, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Nov 09 20:35:00 CST 2014, time=2014-11-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879975, encodeId=e3b518e99759d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 18 21:35:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695523, encodeId=09231695523d5, content=<a href='/topic/show?id=a8aee800603' target=_blank style='color:#2F92EE;'>#细胞能量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78006, encryptionId=a8aee800603, topicName=细胞能量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48c529824825, createdName=sjzlzc017, createdTime=Fri Mar 28 02:35:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844140, encodeId=d4b21844140af, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Feb 16 23:35:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086693, encodeId=8d07208669383, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Nov 09 20:35:00 CST 2014, time=2014-11-09, status=1, ipAttribution=)]
    2014-11-09 liuli5079

相关资讯

Sci Transl Med:维生素E加速小鼠癌变

在小鼠中进行的一项研究发现,两种常用的抗氧化剂——维生素E和一种名为N-乙酰半胱氨酸(NAC)的化合物——能够加速肺癌的生长,而不是遏制这种疾病。 发表在最新出版的《科学—转化医学》上的这项研究成果可能与每天狼吞虎咽服用维生素E补充剂的数百万人的预期正好相 2005年公布的一项调查显示,大约11%的美国成年人会服用维生素E补充剂,其剂量为400国际单位(IU)或更高。而建议的每日摄入量为22.

Science:发现明星癌基因BRCA1的新功能

癌基因BRCA1因能够生成修复损伤DNA的蛋白质,抑制乳腺癌和卵巢癌为世人所知。一项新研究发现它还有可能调控了大脑尺寸。携带BRCA1突变基因的小鼠神经元的数量减少10倍,且具有其他的脑异常。研究作者指出,在人类携带者中BRCA1突变不太可能对脑尺寸和功能造成这样显著的影响,研究结果可能阐明了这一基因在脑进化中的作用。 PLoS Biol 2(5): e134 (2004) 很早以前科学家

Nature:食管鳞状细胞癌基因研究新成果

来自中国医学科学院、深圳华大基因研究院等机构的研究人员,采用全基因组测序、全外显子组测序和比较基因组杂交芯片分析等方法,对来自广东省潮汕地区的158名食管鳞状细胞癌(ESCC)患者展开研究,鉴别出了这类癌症的一些基因组改变。这一重要的研究成果发表在3月16日的《自然》(Nature)杂志上。 领导这一研究的是中国医学科学院副院长詹启敏(Qimin Zhan),其多年来主要从事肿瘤分子生物学研究,

JBC:Fas蛋白或是治疗乳腺癌潜在靶标

来自第二军医大学、浙江大学医学院等处的研究人员,在2014年3月13日的Journal of Biological Chemistry期刊发表的文章指出乳腺癌细胞中Fas信号介导的癌症相关炎症,可能是癌症治疗的一个潜在靶标。 文章的第一作者是第二军医大学医学免疫学国家重点实验室的刘秋燕副教授。通讯作者是第二军医大学曹雪涛院士,曹院士是我国著名的免疫学家,主要从事

Nature Genetics:癌症治疗不能过于狭隘

血管肉瘤(Angiosarcoma)是一种罕见的血管肿瘤,其发病呈散发或者在放疗治疗后出现。科学家之前已经对血管肉瘤开发出针对血管形成相关的特定细胞通路的药物,但是这些药物的药效并不明显。 现在,来自英国桑格研究所(Wellcome Trust Sanger Institute)等机构的研究人员发现,两个新的肿瘤基因可能与一种罕见的高度恶性的血管瘤的进展相关。这些基因可能作为将来治疗的新标志物并

Cell:揭示不完全重编程的致癌机制

来自京都大学iPS细胞研究与应用中心(CiRA)的Yasuhiro Yamada教授领导的一个研究小组,发现当细胞在体内经受不完全重编程时,发生的表观遗传修饰促进了癌症形成。这项重要的研究发表在近期的《细胞》(Cell)杂志上。 iPS细胞和癌细胞具有一个共同的特性:它们都能够无限地增殖,但人们认为癌症是由于一系列的基因突变所引起,而通过体细胞重编程生成的iPS细胞并